GlassScriptPhysician profile
Tracy A Siegfried
NPI 1366598591
$6,726.01
in general payments reported to CMS, 2019-2025
40 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,483 · 2020: $1,124 · 2021: $1,796 · 2022: $1,677 · 2023: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $646.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $867.89 | 2021-2023 | Vraylar, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $851.95 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $824.35 | 2019-2023 | Mounjaro, Jardiance, Trulicity |
| Glaxosmithkline, LLC. | $496.17 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $302.85 | 2021-2023 | |
| Amgen INC. | $269.64 | 2019-2023 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.36 | 2020-2023 | Jardiance |
| Novo Nordisk INC | $258.05 | 2019-2023 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $247.10 | 2019-2023 | |
| Eisai INC. | $220.17 | 2020-2022 | |
| Astellas Pharma US INC | $191.43 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $160.14 | 2020-2022 | |
| Allergan, INC. | $152.99 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $152.65 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $116.94 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Siegfried listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.